- Home
- CDLR vs IMCR Comparison
CDLR vs IMCR Comparison
Compare CDLR & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDLR
- IMCR
- Stock Information
- Founded
- CDLR 2008
- IMCR 2008
- Country
- CDLR Denmark
- IMCR United Kingdom
- Employees
- CDLR N/A
- IMCR N/A
- Industry
- CDLR
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CDLR
- IMCR Health Care
- Exchange
- CDLR Nasdaq
- IMCR Nasdaq
- Market Cap
- CDLR 1.9B
- IMCR 1.8B
- IPO Year
- CDLR N/A
- IMCR 2021
- Fundamental
- Price
- CDLR $20.98
- IMCR $33.81
- Analyst Decision
- CDLR
- IMCR Buy
- Analyst Count
- CDLR 0
- IMCR 8
- Target Price
- CDLR N/A
- IMCR $57.00
- AVG Volume (30 Days)
- CDLR 43.7K
- IMCR 270.5K
- Earning Date
- CDLR 08-26-2025
- IMCR 11-05-2025
- Dividend Yield
- CDLR N/A
- IMCR N/A
- EPS Growth
- CDLR N/A
- IMCR N/A
- EPS
- CDLR 0.78
- IMCR N/A
- Revenue
- CDLR $546,159,718.00
- IMCR $356,145,000.00
- Revenue This Year
- CDLR $116.02
- IMCR $31.83
- Revenue Next Year
- CDLR $80.90
- IMCR $8.50
- P/E Ratio
- CDLR $6.72
- IMCR N/A
- Revenue Growth
- CDLR 277.89
- IMCR 26.78
- 52 Week Low
- CDLR $17.37
- IMCR $23.15
- 52 Week High
- CDLR $28.75
- IMCR $39.33
- Technical
- Relative Strength Index (RSI)
- CDLR 48.91
- IMCR 46.61
- Support Level
- CDLR $20.85
- IMCR $35.33
- Resistance Level
- CDLR $21.70
- IMCR $36.76
- Average True Range (ATR)
- CDLR 0.33
- IMCR 1.43
- MACD
- CDLR -0.01
- IMCR 0.00
- Stochastic Oscillator
- CDLR 55.83
- IMCR 30.79
About CDLR Cadeler AS
Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.